U.S. Markets closed

Intercept Pharmaceuticals, CymaBay’s and Viking’s Competitor

Margaret Patrick
Intercept Pharmaceuticals, CymaBay’s and Viking’s Competitor

Intercept Pharmaceuticals (ICPT) closed at $80.99 on June 12, 0.90% higher than its previous close, 10.93% above its 52-week low of $73.01, and 39.44% below its 52-week high of $133.74.